Bryostatin 1 inhibits phorbol ester-induced apoptosis in prostate cancer cells by differentially modulating Protein Kinase C (PKC) δ translocation and preventing PKCδ-mediated release of tumor necrosis factor-α

Molecular Pharmacology

Volumn 78, Issue 3, 2010, Pages 325-332

  Von Burstin, Vivian A ^a   Xiao, Liqing ^a   Kazanietz, Marcelo G ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRYOSTATIN 1; PHORBOL ESTER; PROTEIN KINASE C DELTA; TUMOR NECROSIS FACTOR ALPHA; ANTINEOPLASTIC AGENT; BRYOSTATIN; ISOENZYME; LACTONE; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL-12-MYRISTATE; PROTEIN KINASE C;

APOPTOSIS; ARTICLE; CANCER CELL; CELL GROWTH; CELL MEMBRANE; CELL SURVIVAL; CYTOKINE RELEASE; ENZYME LOCALIZATION; PRIORITY JOURNAL; PROSTATE CANCER; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; HUMAN; MALE; METABOLISM; PATHOLOGY; PROSTATE TUMOR;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BRYOSTATINS; HUMANS; ISOENZYMES; LACTONES; MALE; PHORBOL ESTERS; PROSTATIC NEOPLASMS; PROTEIN KINASE C; PROTEIN KINASE C-DELTA; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77956251138     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.110.064741     Document Type: Article

References (41)

1. Barry OP and Kazanietz MG (2001) Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. Curr Pharm Des 7:1725-1744.
2. Basu A and Sivaprasad U (2007) Protein kinase Cepsilon makes the life and death decision. Cell Signal 19:1633-1642.
3. Blass M, Kronfeld I, Kazimirsky G, Blumberg PM, and Brodie C (2002) Tyrosine phosphorylation of protein kinase Cdelta is essential for its apoptotic effect in response to etoposide. Mol Cell Biol 22:182-195.
4. Cartee L, Maggio SC, Smith R, Sankala HM, Dent P, and Grant S (2003) Protein kinase C-dependent activation of the tumor necrosis factor receptor-mediated extrinsic cell death pathway underlies enhanced apoptosis in human myeloid leukemia cells exposed to bryostatin 1 and flavopiridol. Mol Cancer Ther 2:83-93.
5. Clamp AR, Blackhall FH, Vasey P, Soukop M, Coleman R, Halbert G, Robson L, Jayson GC, and Cancer Research UK Phase I/II Committee (2003) A phase II trial of bryostatin-1 administered by weekly 24-hour infusion in recurrent epithelial ovarian carcinoma. Br J Cancer 89:1152-1154.
6. Díaz-Rodríguez E, Montero JC, Esparís-Ogando A, Yuste L, and Pandiella A (2002) Extracellular signal-regulated kinase phosphorylates tumor necrosis factor alpha-converting enzyme at threonine 735: a potential role in regulated shedding. Mol Biol Cell 13:2031-2044.
7. Garcia-Bermejo ML, Leskow FC, Fujii T, Wang Q, Blumberg PM, Ohba M, Kuroki T, Han KC, Lee J, Marquez VE, et al. (2002) Diacylglycerol (DAG)-lactones, a new class of protein kinase C (PKC) agonists, induce apoptosis in LNCaP prostate cancer cells by selective activation of PKCalpha. J Biol Chem 277:645-655.
8. Gomel R, Xiang C, Finniss S, Lee HK, Lu W, Okhrimenko H, and Brodie C (2007) The localization of protein kinase Cdelta in different subcellular sites affects its proapoptotic and antiapoptotic functions and the activation of distinct downstream signaling pathways. Mol Cancer Res 5:627-639.
9. Gonzalez-Guerrico AM and Kazanietz MG (2005) Phorbol ester-induced apoptosis in prostate cancer cells via autocrine activation of the extrinsic apoptotic cascade: a key role for protein kinase C delta. J Biol Chem 280:38982-38991.
10. Griner EM and Kazanietz MG (2007) Protein kinase C and other diacylglycerol effectors in cancer. Nat Rev Cancer 7:281-294.
11. Gschwend JE, Fair WR, and Powell CT (2000) Bryostatin 1 induces prolonged activation of extracellular regulated protein kinases in and apoptosis of LNCaP human prostate cancer cells overexpressing protein kinase Calpha. Mol Pharmacol 57:1224-1234.
12. Hennings H, Blumberg PM, Pettit GR, Herald CL, Shores R, and Yuspa SH (1987) Bryostatin 1, an activator of protein kinase C, inhibits tumor promotion by phorbol esters in SENCAR mouse skin. Carcinogenesis 8:1343-1346.
13. Kazanietz MG, Lewin NE, Gao F, Pettit GR, and Blumberg PM (1994) Binding of [26-3H]bryostatin 1 and analogs to calcium-dependent and calcium-independent protein kinase C isozymes. Mol Pharmacol 46:374-379.
14. Lorenzo PS, Bögi K, Acs P, Pettit GR, and Blumberg PM (1997) The catalytic domain of protein kinase Cdelta confers protection from down-regulation induced by bryostatin 1. J Biol Chem 272:33338-33343.
15. McJilton MA, Van Sikes C, Wescott GG, Wu D, Foreman TL, Gregory CW, Weidner DA, Harris Ford O, Morgan Lasater A, Mohler JL, et al. (2003) Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells. Oncogene 22:7958-7968.
16. Meshki J, Caino CC, von Burstin VA, Griner EM, and Kazanietz MG (2010) Regulation of prostate cancer cell survival by protein kinase C ε involves Bad phosphorylation and modulation of the TNFα/JNK pathway. J Biol Chemdoi:10.1074/jbc.M110.128371.
17. Ogbourne SM, Suhrbier A, Jones B, Cozzi SJ, Boyle GM, Morris M, McAlpine D, Johns J, Scott TM, Sutherland KP, et al. (2004) Antitumor activity of 3-ingenyl angelate: plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res 64:2833-2839.
18. Powell CT, Brittis NJ, Stec D, Hug H, Heston WD, and Fair WR (1996) Persistent membrane translocation of protein kinase C alpha during 12-0-tetradecanoylphorbol- 13-acetate-induced apoptosis of LNCaP human prostate cancer cells. Cell Growth Differ 7:419-428.
19. Propper DJ, Macaulay V, O'Byrne KJ, Braybrooke JP, Wilner SM, Ganesan TS, Talbot DC, and Harris AL (1998) A phase II study of bryostatin 1 in metastatic malignant melanoma. Br J Cancer 78:1337-1341.
20. Reddy AB, Ramana KV, Srivastava S, Bhatnagar A, and Srivastava SK (2009) Aldose reductase regulates high glucose-induced ectodomain shedding of tumor necrosis factor (TNF)-alpha via protein kinase C-delta and TNF-alpha converting enzyme in vascular smooth muscle cells. Endocrinology 150:63-74.
21. Reyland ME, Anderson SM, Matassa AA, Barzen KA, and Quissell DO (1999) Protein kinase C delta is essential for etoposide-induced apoptosis in salivary gland acinar cells. J Biol Chem 274:19115-19123.
22. Reyland ME, Barzen KA, Anderson SM, Quissell DO, and Matassa AA (2000) Activation of PKC is sufficient to induce an apoptotic program in salivary gland acinar cells. Cell Death Differ 7:1200-1209.
23. Roberts JD, Smith MR, Feldman EJ, Cragg L, Millenson MM, Roboz GJ, Honeycutt C, Thune R, Padavic-Shaller K, Carter WH, et al. (2006) Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (non-Hodgkin's) lymphoma. Clin Cancer Res 12:5809-5816.
24. Schaar D, Goodell L, Aisner J, Cui XX, Han ZT, Chang R, Martin J, Grospe S, Dudek L, Riley J, et al. (2006) A phase I clinical trial of 12-O-tetradecanoylphorbol-13-acetate for patients with relapsed/refractory malignancies. Cancer Chemother Pharmacol 57:789-795.
25. Schechtman D and Mochly-Rosen D (2002) Isozyme-specific inhibitors and activators of protein kinase C. Methods Enzymol 345:470-489.
26. Shao MX, Ueki IF, and Nadel JA (2003) Tumor necrosis factor alpha-converting enzyme mediates MUC5AC mucin expression in cultured human airway epithelial cells. Proc Natl Acad Sci USA 100:11618-11623.
27. Stone RM, Sariban E, Pettit GR, and Kufe DW (1988) Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells. Blood 72:208-213.
28. Sumitomo M, Ohba M, Asakuma J, Asano T, Kuroki T, Asano T, and Hayakawa M (2002) Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells. J Clin Invest 109:827-836.
29. Szallasi Z, Smith CB, Pettit GR, and Blumberg PM (1994) Differential regulation of protein kinase C isozymes by bryostatin 1 and phorbol 12-myristate 13-acetate in NIH 3T3 fibroblasts. J Biol Chem 269:2118-2124.
30. Tanaka Y, Gavrielides MV, Mitsuuchi Y, Fujii T, and Kazanietz MG (2003) Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway. J Biol Chem 278:33753-33762.
31. Varterasian ML, Mohammad RM, Shurafa MS, Hulburd K, Pemberton PA, Rodriguez DH, Spadoni V, Eilender DS, Murgo A, Wall N, et al. (2000) Phase II trial of bryostatin 1 in patients with relapsed low-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Clin Cancer Res 6:825-828.
32. Wang QJ, Bhattacharyya D, Garfield S, Nacro K, Marquez VE, and Blumberg PM (1999a) Differential localization of protein kinase C delta by phorbol esters and related compounds using a fusion protein with green fluorescent protein. J Biol Chem 274:37233-37239.
33. Wang QJ, Fang TW, Fenick D, Garfield S, Bienfait B, Marquez VE, and Blumberg PM (2000) The lipophilicity of phorbol esters as a critical factor in determining the pattern of translocation of protein kinase C delta fused to green fluorescent protein. J Biol Chem 275:12136-12146.
34. Wang QJ, Lu G, Schlapkohl WA, Goerke A, Larsson C, Mischak H, Blumberg PM, and Mushinski JF (2004) The V5 domain of protein kinase C plays a critical role in determining the isoform-specific localization, translocation, and biological function of protein kinase C-delta and -epsilon. Mol Cancer Res 2:129-140.
35. Wang S, Guo CY, Castillo A, Dent P, and Grant S (1998) Effect of bryostatin 1 on paclitaxel-induced apoptosis and cytotoxicity in human leukemia cells (U937). Biochem Pharmacol 56:635-644.
36. Wang S, Wang Z, Boise LH, Dent P, and Grant S (1999b) Bryostatin 1 enhances paclitaxel-induced mitochondrial dysfunction and apoptosis in human leukemia cells (U937) ectopically expressing Bcl-xL. Leukemia 13:1564-1573.
37. Wang S, Wang Z, Dent P, and Grant S (2003) Induction of tumor necrosis factor by bryostatin 1 is involved in synergistic interactions with paclitaxel in human myeloid leukemia cells. Blood 101:3648-3657.
38. Wheeler DL, Ness KJ, Oberley TD, and Verma AK (2003) Protein kinase Cepsilon is linked to 12-O-tetradecanoylphorbol-13-acetate-induced tumor necrosis factor-alpha ectodomain shedding and the development of metastatic squamous cell carcinoma in protein kinase Cepsilon transgenic mice. Cancer Res 63:6547-6555.
39. Xiao L, Caino MC, von Burstin VA, Oliva JL, and Kazanietz MG (2008) Phorbol ester-induced apoptosis and senescence in cancer cell models. Methods Enzymol 446:123-139.
40. Xiao L, Eto M, and Kazanietz MG (2009) ROCK mediates phorbol ester-induced apoptosis in prostate cancer cells via p21Cip1 up-regulation and JNK. J Biol Chem 284:29365-29375.
41. Zonder JA, Shields AF, Zalupski M, Chaplen R, Heilbrun LK, Arlauskas P, and Philip PA (2001) A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancer. Clin Cancer Res 7:38-42.